-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) commends Ireland’s additional €750,000 pledge, bringing the Republic’s total contribution to €65.75 million for the upcoming three-year period.
-
Reaching the Last Mile – a portfolio of global health programs, investments, and initiatives working to end preventable diseases that affect the world’s most vulnerable communities– welcomes the commitment made by a coalition of partners to accelerat...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced during the World Climate Summit at COP28 in Dubai that more than 70% of its funding – over US$9 billion over the next three years – will be spent in the 50 most clima...
-
A consortium of multilateral development banks and funders, countries, and philanthropies today published the Guiding Principles for Financing Climate and Health Solutions (“Guiding Principles”), announced at the World Climate Action Summit during th...
-
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria held its 50th meeting this week in Geneva, Switzerland. Two months after the release of the Global Fund’s Results Report, Board members praised the unprecedented progress achieved i...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) welcomes a contribution by the Anne and Chris Flowers Foundation of US$1 million to support the Global Fund’s MOSASWA regional grant, a trilateral agreement between the governm...
-
Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the World Health Summit today to accelerate the use of artificial intelligence (AI) in diagnosing tuberculosis (TB), a prev...
-
Three key organizations involved in preventing and responding to HIV in South Africa – AIDS Foundation of South Africa, Beyond Zero, and Networking HIV & AIDS Community of Southern Africa – have placed an initial order of 16,000 dapivirine vaginal ri...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced today a new collaboration with Danaher Corporation (Danaher), a global science and technology innovator who will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic tes...
-
The Global Fund’s 2023 Results Report released today shows a remarkable acceleration of programmatic results in the fight against HIV, TB and malaria, after losses from the COVID-19 pandemic. However, multiple challenges, including climate change and...
-
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolut...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. This financial mechanism uses advanced market...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Unitaid are partnering to accelerate the manufacturing of health products in Africa, with HIV rapid diagnostic...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds GSK and ViiV Healthcare’s combined commitment of US$7.5 million over three years for the Gender Equality Fund, which will help accelerate progress towards gender equality through commun...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the Agence française de développement/Expertise France (AFD/EF) have announced they are renewing and strengthening their program of technical assistance for Chad; it covers the period from 2...
-
Ambassador Dr. John N. Nkengasong, U.S. Global AIDS Coordinator and Special Representative for Global Health Diplomacy, visited Maputo June 14-16. Ambassador Nkengasong was accompanied by UNAIDS Executive Director Winnie Byanyima, who leads the Unite...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) are deeply concerned about the harmful impact of the ...
-
The Laboratory Systems Integration Fund – supported by The Rockefeller Foundation, the Abbott Fund and IQVIA through (RED), and matched by the Global Fund – is supporting an investment of US$54 million toward the development of stronger and better co...
-
Oxygen, a lifesaving medicine to treat acute respiratory illnesses like COVID-19 and pneumonia, is essential for surgery, trauma, emergency and critical care, and treating older persons, pregnant women and newborns. Medical oxygen is also proving to ...
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has committed nearly US$1 million in emergency funding to Mozambique to mitigate the impact of the floods and Cyclone Freddy on malaria programs in the southern provinces of the country.